Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check7 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This represents a small site revision label, likely reflecting an internal update without altering visible study information.SummaryDifference0.0%

- Check14 days agoChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding in 2018. This provides additional funding context for the trial.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating an updated version of the study record. This change reflects an updated revision status on the page without altering the core content shown to users.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page displays a new Revision: v3.6.4, replacing the previous v3.6.3 tag. This indicates a minor version update of the page or its underlying system without changes to the study information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, signaling a small site or document update rather than a content change.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a version update. It does not alter the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.